Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Directly Observed Therapy for the Treatment of Hepatitis C Virus Infection in Injection Drug Users

NCT00247884 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00247884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Directly Observed Therapy for the Treatment of Hepatitis C Virus Infection in Injection Drug Users
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2009
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection